showed a trendP =0.087
Interestingly, not only resveratrol- but also losartan-treated MFS mice showed a trend toward decreased senescence when compared with the MFS placebo group (Figure 2 B; P =0.087 and P =0.113, respectively).
Interestingly, not only resveratrol- but also losartan-treated MFS mice showed a trend toward decreased senescence when compared with the MFS placebo group (Figure 2 B; P =0.087 and P =0.113, respectively).